Antifungals to treatCandida albicans

Use of Liposomal Amphotericin B in Critically III Patients: A Retrospective, Multicenter, Clinical Study

(2014) F. Álvarez-Lerma et al.   JOURNAL OF CHEMOTHERAPY

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy

(2009) Zainab Shahid et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

A Phase 2, Open-Label Study of the Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis

(2009) José A Vazquez et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Activity of Contemporary Antifungal Agents, Including the Novel Echinocandin Anidulafungin, Tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007)

(2009) S. A. Messer et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Immunocompromised Hosts: Immunopharmacology of Modern Antifungals

(2008) R. Ben‐Ami et al.   CLINICAL INFECTIOUS DISEASES

Caspofungin Disk Diffusion Breakpoints and Quality Control

(2008) S. D. Brown et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

(2007) A. Pascual et al.   CLINICAL INFECTIOUS DISEASES

New and emerging treatments for fungal infections

(2007) A. C. Pasqualotto et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY